Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Monday, December 2, 2024

Different color temperature on the effectiveness of rehabilitation training in patients with ischemic strokeA prospective, single-center, randomized controlled clinical trial

Does your competent? doctor have enough functioning brain cells to add this therapy to all these previous ones?

Oh, you have nothing from this earlier research! So, you don't have a functioning stroke doctor, do you?

 Different color temperature on the effectiveness of rehabilitation training in
patients with ischemic strokeA prospective, single-center, randomized
controlled clinical trial

Nan Wang
Shanghai Yangzhi Rehabilitation Hospital, Tongji University
Yan Xue
Shanghai Yangzhi Rehabilitation Hospital, Tongji University
Tongyue Wang
Tongji University
Fengxi Qiu
Shanghai Yangzhi Rehabilitation Hospital, Tongji University
Cheng Li
Shanghai Yangzhi Rehabilitation Hospital, Tongji University
Zhiyuan Wang
Shanghai Yangzhi Rehabilitation Hospital, Tongji University
Jianke Jiang
Shanghai Yangzhi Rehabilitation Hospital, Tongji University
Yi Lu
Shanghai Yangzhi Rehabilitation Hospital, Tongji University
Yingqi Shao
Shanghai Yangzhi Rehabilitation Hospital, Tongji University
Zhongfei Bai
Shanghai Yangzhi Rehabilitation Hospital, Tongji University
Danmei Lan
Shanghai Yangzhi Rehabilitation Hospital, Tongji University
Qilong Hu
Shanghai Yangzhi Rehabilitation Hospital, Tongji University
Hengjing Wu
Shanghai Yangzhi Rehabilitation Hospital, Tongji University
Research Article
Keywords: Light therapy, Color temperature, Ischemic stroke, Cold light, Rehabilitation
Posted Date: November 18th, 2024
DOI: https://doi.org/10.21203/rs.3.rs-5322014/v1
License:   This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License
Additional Declarations: No competing interests reported.

Abstract

Background: 

Stroke is a leading cause of death and disability worldwide, especially in China, where its incidence is rising. Post-stroke rehabilitation is crucial for restoring neurological function and improving quality of life. Light therapy, a non-pharmacological intervention, is gaining attention for its potential to promote neuroplasticity and enhance brain circulation. Warm and cold light, differing in color temperature, have shown benets in improving sleep, neurological recovery, and emotional well-being in stroke patients, though their mechanisms are not fully understood. This study explores the effects of different light color temperatures on stroke recovery to optimize rehabilitation approaches.

Methods: 

A randomized controlled trial conducted at the Shanghai Yangzhi Rehabilitation Hospital (Shanghai Sunshine Rehabilitation Center) (Chinese Clinical Trial Registry: ChiCTR2200057541).
48 patients with ischemic stroke were randomly divided into three groups (1:1:1): warm light group (WLG, 500 lx, 3000 K, n=16), cold light group (CLG, 500lx, 6500 K, n=16), and control group (CG, 500 lx, 5000 K, n=16). Participants underwent 60 minutes of rehabilitation therapy daily from Monday to Friday, between 8:30 AM and 9:30 AM, in different color temperature light environments. The primary outcome was the National Institutes of Health Stroke Scale(NIHSS). Secondary outcomes included the Short Form-36 (SF-36), Self-Rating Sleep Scale (SRSS), and levels of interleukin 6 (IL-6), norepinephrine (NE), and melatonin (MT).

Results: 

The study found that the CLG (-2.00(2.75), p0.001) out-performed WLG (-0.00(1.75),
p = 0.003) and CG (-0.00(0.00), p0.001) in NIHSS scores. There was also a signicant decrease in SRSS scores in the CLG (-5.50(5.50), p(0.001) compared with WLG(-1.00(3.00), p=0.026) and CG(-1.00(3.00), p=0.040). SF-36 assessments indicated better management of role limitations due to signicant improvements in energy/fatigue levels in the CLG(5.00(13.75), p=0.011) compared with WLG (p <0.001) and CG (p <0.001)), and superior social functioning compared to both WLG (p <0.001) and CG (p=0.001). In terms of pain, the CLG showed a signicant improvement (32.50(15.50), p=0.016) compared to WLG (p=0.032) and CG (p=0.007). For general health, the CLG showed positive changes (p=0.009). The results were signicant improvement in health change within the CLG compared to the CG(p=0.002). Lastly, MT levels in the CLG (-4.13±5.10,p = 0.006) signicantly decreased compared with WLG (p = 0.018). No signicant changes in NE and IL-6 levels were observed across all groups, and no apparent adverse events were reported.

Conclusions: 

Cold light therapy showed signicant improvement in multiple indicators, particularly in NIHSS, SRSS, and SF-36's energy/fatigue, pain, and health change aspects, and also demonstrated a reduction in MT levels. These results indicated the substantial potential of cold light therapy as an
adjunct treatment for accelerating neurological rehabilitation and managing related complications in ischemic stroke.
Trial registration: Chinese Clinical Trial Registry, number: ChiCTR2200057541. Registered March 14, 2022.

No comments:

Post a Comment